受强制性开放获取政策约束的文章 - Nicolas R. Barthélemy了解详情
无法在其他位置公开访问的文章：1 篇
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited …
SA Schultz, L Liu, AP Schultz, CD Fitzpatrick, R Levin, JP Bellier, ...
The Lancet Neurology 23 (9), 913-924, 2024
强制性开放获取政策： Michael J Fox Foundation
可在其他位置公开访问的文章：45 篇
Tau kinetics in neurons and the human central nervous system
C Sato, NR Barthélemy, KG Mawuenyega, BW Patterson, BA Gordon, ...
Neuron 97 (6), 1284-1298. e7, 2018
强制性开放获取政策： US National Institutes of Health, Alzheimers's UK
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ...
Nature medicine 26 (3), 398-407, 2020
强制性开放获取政策： US National Institutes of Health, UK Medical Research Council, Federal …
Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
NR Barthélemy, K Horie, C Sato, RJ Bateman
Journal of Experimental Medicine 217 (11), e20200861, 2020
强制性开放获取政策： US National Institutes of Health, Alzheimers's UK
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
S Janelidze, D Bali, NJ Ashton, NR Barthélemy, J Vanbrabant, E Stoops, ...
Brain 146 (4), 1592-1601, 2023
强制性开放获取政策： US National Institutes of Health, Knut and Alice Wallenberg Foundation …
Neurofilaments: neurobiological foundations for biomarker applications
AR Gafson, NR Barthélemy, P Bomont, RO Carare, HD Durham, JP Julien, ...
Brain 143 (7), 1975-1998, 2020
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
NR Barthélemy, RJ Bateman, C Hirtz, P Marin, F Becher, C Sato, ...
Alzheimer's research & therapy 12, 1-11, 2020
强制性开放获取政策： US National Institutes of Health, Alzheimers's UK
Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests
NR Barthélemy, G Salvadó, SE Schindler, Y He, S Janelidze, LE Collij, ...
Nature medicine 30 (4), 1085-1095, 2024
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council, Alzheimers's …
Tau phosphorylation rates measured by mass spectrometry differ in the intracellular brain versus extracellular cerebrospinal fluid compartments and are differentially affected …
NR Barthélemy, N Mallipeddi, P Moiseyev, C Sato, RJ Bateman
Frontiers in Aging Neuroscience 11, 121, 2019
强制性开放获取政策： US National Institutes of Health, Alzheimers's UK
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ...
The Lancet Neurology 21 (4), 329-341, 2022
强制性开放获取政策： US National Institutes of Health, German Research Foundation, Swedish …
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
K Horie, NR Barthélemy, C Sato, RJ Bateman
Brain 144 (2), 515-527, 2021
强制性开放获取政策： US National Institutes of Health, Alzheimers's UK
Sleep deprivation affects tau phosphorylation in human cerebrospinal fluid
NR Barthélemy, H Liu, W Lu, PT Kotzbauer, RJ Bateman, BP Lucey
Annals of neurology 87 (5), 700-709, 2020
强制性开放获取政策： US National Institutes of Health
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
K Horie, G Salvadó, NR Barthélemy, S Janelidze, Y Li, Y He, B Saef, ...
Nature medicine 29 (8), 1954-1963, 2023
强制性开放获取政策： US National Institutes of Health, Knut and Alice Wallenberg Foundation …
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
ECB Johnson, S Bian, RU Haque, EK Carter, CM Watson, BA Gordon, ...
Nature medicine 29 (8), 1979-1988, 2023
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research …
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
NR Barthélemy, B Saef, Y Li, BA Gordon, Y He, K Horie, E Stomrud, ...
Nature Aging 3 (4), 391-401, 2023
强制性开放获取政策： US National Institutes of Health, Knut and Alice Wallenberg Foundation …
Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated tau to total tau ratios
S Janelidze, NR Barthélemy, Y He, RJ Bateman, O Hansson
JAMA neurology 80 (5), 516-522, 2023
强制性开放获取政策： US National Institutes of Health, Knut and Alice Wallenberg Foundation …
CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
K Horie, NR Barthélemy, S Spina, L VandeVrede, Y He, RW Paterson, ...
Nature medicine 28 (12), 2547-2554, 2022
强制性开放获取政策： US National Institutes of Health, Chan Zuckerberg Initiative
SILK studies—capturing the turnover of proteins linked to neurodegenerative diseases
RW Paterson, A Gabelle, BP Lucey, NR Barthélemy, CA Leckey, C Hirtz, ...
Nature Reviews Neurology 15 (7), 419-427, 2019
强制性开放获取政策： US National Institutes of Health, Knut and Alice Wallenberg Foundation …
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons
LS Capano, C Sato, E Ficulle, A Yu, K Horie, JS Kwon, KF Burbach, ...
Cell Stem Cell 29 (6), 918-932. e8, 2022
强制性开放获取政策： US National Institutes of Health, Alzheimers's UK, UK Medical Research …
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
K Horie, NR Barthélemy, N Mallipeddi, Y Li, EE Franklin, RJ Perrin, ...
Acta Neuropathologica Communications 8, 1-14, 2020
强制性开放获取政策： US National Institutes of Health, Alzheimers's UK
出版信息和资助信息由计算机程序自动确定